Lupin’s cholesterol-lowering drug Perindopril recalled in US

The US Food and Drug Administration (USFDA) has recalled all lots of Lupin Pharma's cholesterol-lowering drug perindopril 2 and 4 mg packs of 100's for "not meeting specifications overtime", according to information on US drug wholesaler Morris & Dickson's website.
Lupin, however, has denied the recall. Perindopril is used in cholesterol reduction and also to treat hypertension and congestive heart failure. In February, Lupin recalled 14,000 bottles of Lisinopril 30 mg tablets from the US market, FDA website said.Cholesterol-lowering drug lisinopril, which is manufactured in the company's Goa facility, is one of its largest selling drugs by revenue. It has a total market size of $45 million. When contacted, the company's spokesperson said: "We received a complaint of one bottle of lisinopril tablets containing one tablet of Lupin's imipramine. As an abundant precaution, we voluntarily recalled the batch." The recall is limited to one batch worth around $15,000. However, analysts said the lisinopril recall is not likely to have any major impact on the company's revenue as it involves only a small batch.

No comments:

Post a Comment